After surgery to repair a hernia, the muscle in the damaged area often remains weaker than the surrounding tissue. Because of this, surgical mesh is often used to reinforce the area where protrusion occurs, with a goal of limiting the risk of recurrent herniation. In many cases, successful use of mesh can result in a repair that lasts longer and holds up to greater stress than muscle stitching alone.
Bard is a manufacturer of hernia mesh. Unfortunately, the company has been implicated in producing a substandard product that puts patient at greater than normal risk of complications, including:
- Bowel adhesion
- Intestinal blockage
- Recurrent pain or recurrent hernia
The reason for these problems might be linked to the plastic used in the mesh. Eschewing the product used in previous iterations by other companies, Bard used Marlex plastic, which has been shown in some research to fragment more easily than other types. This fragmentation is associated with many of the increased risks associated with this brand.
Trust in the medical profession is important, particularly when specialists are recommending treatments patients may be unfamiliar with. Anything that damages that trust puts the public at risk, as people will opt out of potentially life-saving procedures. Bard violated that public trust by releasing a defective version of an important product. Now many people will first hear of surgical mesh in regards to patients who have suffered or even died due to Bard’s bad practices.
If you or someone you love has suffered side effects from a surgical mesh, please reach out to an experienced attorney. So long as those wronged by dangerous medical practices fail to hold companies accountable, Bard and others of its ilk will continue to put people’s health at risk to boost their bottom line.